| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.03 |